Yu Cao

2.9k total citations · 1 hit paper
70 papers, 2.1k citations indexed

About

Yu Cao is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Yu Cao has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Pharmacology and 12 papers in Physiology. Recurrent topics in Yu Cao's work include Alzheimer's disease research and treatments (12 papers), Gut microbiota and health (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Yu Cao is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Gut microbiota and health (6 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Yu Cao collaborates with scholars based in China, United States and United Kingdom. Yu Cao's co-authors include Hao Li, Lina Ma, Hui Pei, Huiqin Zhang, Xuefan Jiang, Ming Zhao, Wei Wei, Yao Yao, Longtao Liu and Yarong He and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Stroke.

In The Last Decade

Yu Cao

67 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

2021 384 citations Huiqin Zhang, Wei Wei et al. International Journal of Biological Sciences profile →

Peers

Countries citing papers authored by Yu Cao

Since Specialization

Citations

This map shows the geographic impact of Yu Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Cao more than expected).

Fields of papers citing papers by Yu Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Cao. The network helps show where Yu Cao may publish in the future.

Co-authorship network of co-authors of Yu Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Cao. A scholar is included among the top collaborators of Yu Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Cao. Yu Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Arbutin ameliorated depression by inhibiting neuroinflammation and modulating intestinal flora 2025 ·Phytomedicine ·Yu Cao, (unknown), Yudi Zhao, (unknown), Zicheng Zhang, (unknown), J. H. Ning, Qinghua Song, (unknown), Ling He, Tong Chen	3
2	Viability and transcriptional responses of multidrug resistant E. coli to chromium stress 2023 ·Environmental Pollution ·(unknown), Yu Cao, Lanning Wang, Min Wang, Qiang Wang, Qingxiang Yang	4
3	Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus 2023 ·Microbiology Spectrum ·(unknown), Weifeng Yang, Zhiyuan Liu, Guijian Liu, Dongying Li, Yanan Sun, (unknown), Shuhua Ma, Yu Cao, Xuefan Jiang, Sylvie Chevalier, Pierre Cornélis, Qing Wei, Yi Wang	9
4	Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway 2023 ·Frontiers in Neuroscience ·Wei Wei, (unknown), Tingting Zhang, Jiayu Wen, Zhen Zhang, (unknown), Yu Cao, Hao Li	16
5	The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology 2023 ·Frontiers in Neuroscience ·(unknown), Wei Wei, Jiayu Wen, Yu Cao, Hao Li	10
6	Exploring the effects of Qijiao Shengbai capsule on leukopenic mice from the perspective of intestinbased on metabolomics and 16S rRNA sequencing 2023 ·Heliyon ·Yu Cao, Shuo Zhang, Li Tang, Yixuan Chen, (unknown), Li Liu, (unknown)	6
7	Analysis of Spatiotemporal Heterogeneity of Glacier Mass Balance on the Northern and Southern Slopes of the Central Tianshan Mountains, China 2022 ·Water ·Lin Liu, Hao Tian, (unknown), Hongjin Chen, Zhengyong Zhang, (unknown), (unknown), (unknown), Yu Gao, (unknown), Mingyu Zhang, Xin Yi, Yu Cao	4
8	Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma 2022 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), Lianghe Mei, Weihong Lin, Lin Wang, Yu Cao, Kai Li, Fang Bai	15
9	Analysis of the Value of the Blood Urea Nitrogen to Albumin Ratio as a Predictor of Mortality in Patients with Sepsis 2022 ·Journal of Inflammation Research ·(unknown), (unknown), Ye Liao, (unknown), Bofu Liu, Yarong He, (unknown), (unknown), (unknown), Yu Cao	25
10	Total Glucosides of Paeonia lactiflora for Safely Reducing Disease Activity in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis 2022 ·Frontiers in Pharmacology ·Yifan Chen, (unknown), Yu Cao, Nannan Li	15
11	Possible Mechanisms of Tau Spread and Toxicity in Alzheimer’s Disease 2021 ·Frontiers in Cell and Developmental Biology ·Huiqin Zhang, Yu Cao, Lina Ma, Yun Wei, Hao Li	71
12	Distribution of antibiotic resistance genes from human and animal origins to their receiving environments: A regional scale survey of urban settings 2021 ·Environmental Pollution ·Yuan Wei, (unknown), Yu Cao, Qingxiang Yang, Luqman Riaz, Qiang Wang	22
13	Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease breakdown → 2021 ·International Journal of Biological Sciences ·Huiqin Zhang, Wei Wei, Ming Zhao, Lina Ma, Xuefan Jiang, Hui Pei, Yu Cao, Hao Li	384
14	Enlightenment on oscillatory properties of 23 class B notifiable infectious diseases in the mainland of China from 2004 to 2020 2021 ·PLoS ONE ·Chuanliang Han, Meijia Li, Naem Haihambo, Yu Cao, Xixi Zhao	17
15	<p>Identifying the Mechanisms and Molecular Targets of Yizhiqingxin Formula on Alzheimer’s Disease: Coupling Network Pharmacology with GEO Database</p> 2020 ·Pharmacogenomics and Personalized Medicine ·Tingting Zhang, Linlin Pan, Yu Cao, Nanyang Liu, Wei Wei, Hao Li	6
16	Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation 2017 ·Evidence-based Complementary and Alternative Medicine ·Yang Yang, (unknown), (unknown), Zhiyong Wang, Yu Cao, Jiangang Liu, Hao Li	13
17	Procalcitonin in Crohn's disease with fever episodes, a variable to differentiate intra-abdominal abscess from disease flares 2016 ·International Journal of Surgery ·Xiaolong Ge, Dong Hu, Yu Cao, Zhijian Liu, Chao Ding, Hongliang Tian, Jianfeng Gong, Weiming Zhu, Ning Li, Jieshou Li	10
18	Cell-Culture Models of the Blood–Brain Barrier 2014 ·Stroke ·Yarong He, Yao Yao, Stella E. Tsirka, Yu Cao	132
19	Synthesis, Electrochemistry, and Hydrolysis of Anthraquinone Derivatives 2009 ·Synthetic Communications ·Yu Cao, Daniel Rabinowitz, Dabney W. Dixon, Thomas L. Netzel	3
20	Photoreactivation of (6-4) photolyase in Dunaliella salina 2008 ·FEMS Microbiology Letters ·(unknown), (unknown), Yan Xiong, Hui Xu, (unknown), Yu Cao, (unknown), (unknown), Yi Cao	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact